Wednesday, October 27, 2010: 2:00 PM-5:00 PM
Chairs:
Discussant:
12.1
Drug Abuse at the 8-Year Follow-up of the MTA: Does Stimulant Treatment History Predict?
Brooke S.G. Molina, Ph.D.
University of Pittsburgh, Pittsburgh, PA
James M. Swanson, Ph.D.
UCI Child Development Center, Irvine, CA
L. Eugene Arnold, M.D.
Ohio State University, Columbus, OH
Patricia Houck, M.S.
Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA
Bo Lu, Ph.D.
Ohio State University, Columbus, OH
Sue Marcus, Ph.D.
Columbia Univeristy, New York State Psychiatric Institute, New York, NY
MTA Cooperative Group, M.D.
, Columbus, OH
12.2
Prospective Effects of Peer Rejection in Children with ADHD on Substance Use and Mental Health in Adolescence
Sylvie Mrug, Ph.D.
University of Alabama at Birmingham, Birmingham, AL
Betsy Hoza, Ph.D.
University of Vermont, Burlington, VT
Brooke S.G. Molina, Ph.D.
University of Pittsburgh, Pittsburgh, PA
12.3
Mining the Meanings of ADHD, Treatment, and Substance Use/Abuse: The MTA Turning Points Study
Desiree W. Murray, Ph.D.
Duke University Medical Center, Durham, NC
Peter S. Jensen, M.D.
The REACH Institute, The Mayo Clinic, Rochester, MN
Stephen P. Hinshaw, Ph.D.
University of California Berkeley, Berkeley, CA
Karen C. Wells, Ph.D.
Duke University Medical Center, Durham, NC
Thomas Weisner, Ph.D.
University of California at Los Angeles, Los Angeles, CA
12.4
Maternal Substance Exposure and Dopamine Genes of the Child Affect Outcomes in ADHD
Timothy Wigal, Ph.D.
University of California, Irvine, Irvine, CA
Annamarie Stehli, M.P.H.
University of California at Irvine, Irvine, CA
L. Eugene Arnold, M.D.
Ohio State University, Columbus, OH
Jeffrey H. Newcorn, M.D.
Mount Sinai School of Medicine, New York, NY
Brooke S.G. Molina, Ph.D.
University of Pittsburgh, Pittsburgh, PA
James M. Swanson, Ph.D.
UCI Child Development Center, Irvine, CA
Sponsored by the AACAP
Partially supported by an educational grant from the
National Institute on Drug Abuse
